Sign up for e-mail, text message alerts or update your contact info!
Sign Up Button for email or text message alerts

Aaron Ford, Ben Kieckhefer, Paul Anderson and Irene Bustamante Adams lead Big PhRMA Money Race

pills

SEIU Nevada is joining forces with Culinary Local 226 and the NV Diabetes Political Coalition in a legislative effort to cap the high price of drugs that are integral to the treatment and control of diabetes.

“We’ve heard from our home care workers who have no health insurance and simply can’t afford to pay $800 a month for medications to control their conditions,” said SEIU Nevada President Cherie Mancini.  “And we know from our health care workers the heart break of treating patients who develop severe complications from their untreated disease.”

The pharmaceutical industry contributed more than $120,000 to Nevada lawmakers in 2015-16.  Democratic leader Aaron Ford led the Senate with $10,500 in pharmaceutical company contributions while Republican Ben Kieckhefer came in second place with $9500.   In the Assembly, Paul Anderson led Republicans with $11,500 in contributions and Irene Bustamante Adams led Dems with $9750.  Here’s an individual breakdown:

Nevada State Senate Contributions from pharmaceutical interests
Kelvin Atkinson
Pfizer 11/4/16 $1500
PhRMA 11/15/16 $1000
Novartis 9/16/16 $500
Astra Zeneca 9/23/16 $500
PhRMA 1/7/16 $1000
Astella Pharma 5/11/16  $750
Astella Pharma 9/28/15 $1000
Pfizer Inc 11/25/15 $1000
Express Script 12/27/16 $1250
Nicole Cannizzaro
Pfizer 12/22/16  $750
Moises Denis 
Astellas Pharma US 8/17/15 $750
Patricia Farley 
Astellas Pharma US Inc 5/20/16 $750
PhRMA 9/23/16 $1000
PhRMA 12/23/16 $1000
Astellas Pharma US Inc 8/17/15 $1500
Pfizer 11/25/15 $750
Express Scripts 1/6/16 $500
Aaron Ford 
PhRMA 11/9/16 $1500
Pfizer 11/27/16 $500
Pfizer 11/27/16 $1000
Novartis 10/31/16 $500
Bristol Myers Squibb Company 7/15/16 $500
Pfizer 9/22/15 $1250
PhRMA 1/5/16 $1000
Bristol-Myers Squibb 1/16/16 $500
Astellas Pharmacy 5/3/16 $750
Astellas Pharma 8/17/15 $1000
Astra Zeneca 9/8/16 $500
Express Scripts 12/14/16 $1500
Express Scripts 11/16/15 $500
Heidi Gansert 
PhRMA 1/21/16 $500
Pete Goicoechea 
PhRMA 1/26/16 $1000
Scott Hammond 
Pharmaceutical Research and Manufacturers of America 7/12/16 $1000
Astellas Pharma US Inc 10/29/15 $750
Joe Hardy 
PhRMA 1/7/16 $1000
Astellas Pharma US, Inc. 5/18/16 $500
PhRMA 11/14/16 $1000
Astellas Pharma US, INC 10/8/15 $1000
The Galaxo Smith Kline PAC 12/3/15 $500
Becky Harris
Astellas Pharma US Inc. 6/3/16 $500
Astellas Pharma US Inc. 8/17/15 $1000
Express Scripts 11/16/15 $500
Ben Kieckhefer 
PhRMA 2/10/16 $1000
PhRMA 12/15/16 $1000
Allergan USA Inc 2/29/16 $500
Astellas Pharma US, INC. 5/27/16 $500
Eli Lilly and Company 12/28/16 $4000
Express Scripts 12/28/16 $500
Pfizer Inc 10/25/15 $500
Astella Pharma US Inc 10/25/15 $1000
Express Scripts 12/9/15 $500
Mark Manendo 
PhRMA 1/4/16 $1000
Pfizer 11/3/16 $500
Astellas Pharma US Inc 9/28/15 $750
Pfizer 11/12/15 $500
Michael Roberson 
Bristol Myers Squibb 9/15/16 $500
Astra Zeneca 9/15/16 $500
Novartis 9/15/16 $300
Astellas Pharma 9/29/16 $750
PhRMA 12/1/16 $1500
Express Scripts 12/22/16 $1250
Johnson and Johnson 12/21/16 $200
James Settlemeyer 
PhRMA 1/22/16 $1000
Astella Pharma US Inc 5/3/16 $500
Astella Pharma US Inc 8/17/15 $1000
Pfizer Inc 9/22/15 $1500
Pfizer Inc 11/7/16 $500
Pat Spearman 
Astellas Pharma 5/17/16 $750
Express Scripts 12/18/16 $1250
Pfizer 11/7/16 $500
Joyce Woodhouse 
Express Scripts 12/14/16 $750
Pfizer 12/22/16 $750
Bristol Myers Squibb 1/12/16 $500
Nevada State Assembly Contributions from pharmaceutical interests 
Elliot Anderson 
PhRMA 11/15/16 $500
PhRMA 10/7/16 $1000
Paul Anderson 
Allergan 11/10/16 $500
Eli Lily and Company 11/10/16 $4000
PhARMA 11/29/16 $1500
PhARMA 7/5/16 $1000
Astra Zeneca 10/3/16 $500
Astellas Pharma US INC 5/31/15 $750
Astellas Pharma US INC 9/25/15 $750
Pfizer 11/12/15 $1500
Bristol-Myers Squibb Company 3/29/16 $500
Express Scripts 11/16/15 $500
Nelson Araujo 
Amgen 12/12/16 $750
Pfizer 11/3/16 $500
Astellas Pharma US 5/3/16 $500
Teresa Benitez-Thompson 
Pfizer 11/7/16 $750
Pharma 11/4/16 $500
Pfizer 12/14/16 $500
Astellas Pharma US, Inc.  5/13/16 $500
Express Scripts 12/12/16 $1250
Pharmaceutical Researchers and Manufacturers 7/9/16 $1000
Irene Bustamante Adams 
Pfizer Inc 11/14/16 $500
Pfizer Inc 11/14/16 $1000
PhRMA 11/15/16 $1500
Amgen 12/21/16 $1000
Pharmaceutical Research and Manufacturers of America 7/5/16 $1000
Novartis Pharmaceuticals Corporate 9/20/16 $500
Bristol Myers Squibb 9/20/16 $500
AstraZeneca 9/20/16 $500
Sanofi Aventis 9/27/16 $500
Bristol Myers Squibb 1/20/16 $1000
Astellas Pharma US, Inc 5/13/16 $500
Astellas Pharma US, Inc 9/28/16 $750
Express Scripts 12/15/15 $500
Derek Armstrong
PhRMA 1/20/16 $1000
PhRMA 11/19/16 $1000
Maggie Carlton 
Pfizer 11/22/16 $500
Olivia Diaz
PhRMA 11/12/16 $500
AMGEN 12/17/16 $500
PhRMA 1/4/16 $1000
Astellas Pharma US, INC 9/28/15 $750
Christopher Edwards
Astellas Pharma US, INC 8/17/15 $500
John Ellison 
Pfizer 12/1/15 $500
Edgar Flores 
Express Scripts 12/30/16 $500
Jason Frierson 
PhRMA 11/9/16 $1500
Pfizer 12/14/16 $750
Express Scripts 12/14/16 $1500
Johnson & Johnson Corporate Political Fund 11/3/16 $200
Astra Zeneca 9/24/16 $500
Novartis Pharmaceuticals 9/24/16 $300
Bristol Myers Squibb Company 9/24/16 $500
Sanofi Aventis 10/13/16 $500
Astrellas Pharma 5/16/16 $1000
John Hambrick 
PhRMA 11/16/16 $500
PhRMA 1/8/16 $1000
Astellas Pharma US INC 10/30/15 $750
 
Amber Joiner
Allergan USA 2/16/16 $500
Amgen 12/28/16 $750
Dina Neal 
Pfizer Inc 11/20/15 $500
Pfizer Inc 11/2/16 $500
Astellas Pharma US Inc 10/30/15 $750
Erv Nelson
Astellas Pharma US INC 10/27/15 $500
 
James Ohrenschall 
Pfizer 11/3/16 $500
Pfizer 11/19/15 $500
James Oscarson
Pharma 11/9/16 $1000
Express Scripts 12/30/16 $500
Express Scripts 11/30/15 $500
Pharma 7/5/16 $500
PhRMA 1/4/16 $500
Astellas Pharma US Inc 5/3/16 $500
Astellas Pharma US Inc 10/6/15 $750
Astellas Pharma US Inc 8/17/15 $750
 
Mike Sprinkle 
PhRMA 11/15/16 $500
Sanofi 7/1/16 $500
PhRMA 1/15/16 $500
Astellas Pharma 3/11/16 $500
Takeda Pharmaceuticals USA 4/7/16 $500
Pfizer 5/2/16 $1000
Amgen 12/23/16 $1000
Robin Titus 
Pharmaceutical Research and Manufacturers of America $500
Amgen 12/12/16 $500
Jill Tolles
Pfizer 9/27/16 $500
Jim Wheeler
AMGEN 12/20/16 $750
Steve Yeager 
Pfizer, Inc..  12/21/16 $500

 

In Nevada today, approximately 281,355 Nevada adults, or 12.4%, have diabetes, including 75,000 who do not know they have the disease. Another 787,000 of Nevada adults, or 38.5%, have pre-diabetes.  According to recent estimates, during their lifetime, at least 1 in 3 adults will develop diabetes by 2050; half of all Latinos and half of African-American women nationally are projected to develop the disease (Centers for Disease Control and Prevention).  Children who develop the disease face a lifetime of medication and disease management.

Diabetes is a public health epidemic that costs Nevadans $2.4 billion every year in medical costs.  Prescribed retail pharmaceuticals account for an estimated 57.6% of total diabetes healthcare spending. Insulin, the primary drug for controlling diabetes, was discovered 95 years ago, but drug companies have raised insulin prices as much as 450% beyond inflation since 1996.

“Diabetes does not discriminate and this epidemic is not a partisan political issue,” said Geoconda Arguello-Kline, Secretary-Treasurer for the Culinary Union and Chairwoman of the Nevada Diabetes Political Coalition. “Republicans, Independents and Democrats can work together for the good of Nevadans.”

Every day in the United States: 3,835 Americans will be diagnosed with diabetes and it will cause 200 Americans to undergo an amputation, 136 to enter end-stage kidney disease treatment, and 1,795 to develop severe retinopathy that can lead to vision loss and blindness (American Diabetes Association).

 

 

 

Did you like this? Share it:

Comments are closed.